ACT001 is an Orally Active PAI-1 Inhibitor
Glioblastoma (GBM) is the most common and most aggressive primary malignant brain tumour in adults, with a high morbidity, high mortality and poor patient prognosis. Platinum-based drugs, including cisplatin, are…